title: [Triple combination antimicrobial therapy of Helicobacter pylori and basal levels of serum gastrin].
abstract: BACKGROUND
  The etiopathogenic relationship of Helicobacter pylori (HP) infection to chronic active antrumgastritis and peptic ulcer disease has been confirmed by a number of studies. The key role in the development of peptic lesions belongs to hypergastrinemia. This is supposed to be related to ammonium synthesis in the antral area influenced (promoted by HP and resulting in interruption) weakening of the negative feedback mechanism maintaining intraluminal acidity.
  
  
  OBJECTIVE
  In our present study we focus our attention to the effectiveness of triple antimicrobial therapy in HP positive patients with chronic active antrumgastritis residing in the lowering of the level of serum gastrin.
  
  
  METHODS
  There was a group of 15 patients in our current study with HP positivity as well as chronic active antrumgastritis documented by endoscopy, histology, microbiology and serology respectively. Endoscopical and histological findings were classified according to "The Sydney System". The whole group was evaluated on an ambulatory basis, those with active ulcer, endocrinopathy and biliary tract disorders were excluded. The basal level of serum gastrin was evaluated by RIA-test-gastrin before and after successful antimicrobial therapy.
  
  
  RESULTS
  In our group of 15 patients with HP infection in coexistence with chronic active antrumgastritis we have found a significant decrease in the basal level of serum gastrin (p = 0,01) after successful therapy.
  
  
  CONCLUSIONS
  The decrease in the basal level of serum gastrin after eradication of HP confirms the importance of HP infection in the pathogenesis of peptic lesions in stomach and duodenum. We consider the antimicrobial therapy in chronic active antrumgastritis in HP positive patients to be a fully indicated therapeutic approach. (Tab. 1, Fig. 1, Ref. 10.).
authors.affiliation: II. interná klinika Dérerovej NsP v Bratislave, Slovakia.
authors.forename: L
authors.initials: L
authors.lastname: Jurgos
authors.forename: I
authors.initials: I
authors.lastname: Duris
authors.forename: M
authors.initials: M
authors.lastname: Bátovský
authors.forename: M
authors.initials: M
authors.lastname: Simkovicová
authors.forename: M
authors.initials: M
authors.lastname: Pauer
authors.forename: F
authors.initials: F
authors.lastname: Dorociak
authors.forename: M
authors.initials: M
authors.lastname: Majercík
authors.forename: H
authors.initials: H
authors.lastname: Kratochvílová
authors.forename: L
authors.initials: L
authors.lastname: Valko
authors.forename: P
authors.initials: P
authors.lastname: Paulen
mesh_terms: D000328:Adult; D000658:Amoxicillin / Q000008:administration & dosage; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D005260:Female; D005755:Gastrins / Q000097:blood*; D005756:Gastritis / Q000097:blood / Q000188:drug therapy* / Q000382:microbiology; D016481:Helicobacter Infections / Q000097:blood / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D008297:Male; D008795:Metronidazole / Q000008:administration & dosage; D008875:Middle Aged
chemical_list: D005755:Gastrins; D008795:Metronidazole; D000658:Amoxicillin
vernacular_title: Trojkombinacná antimikróbna liecba Helicobacter pylori a bazálna hladina sérového gastrínu.